Dulera FDA Approval History
Last updated by Judith Stewart, BPharm on Jan 28, 2021.
FDA Approved: Yes (First approved June 22, 2010)
Brand name: Dulera
Generic name: mometasone furoate and formoterol fumarate
Dosage form: Inhaler
Company: Merck
Treatment for: Asthma
Dulera (mometasone furoate and formoterol fumarate) is a combination product containing a corticosteroid and a long-acting beta2-adrenergic agonist indicated for the treatment of asthma in patients 5 years of age and older.
Development timeline for Dulera
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
